Provided by Tiger Trade Technology Pte. Ltd.

YieldMax MRNA Option Income Strategy ETF

39.37
+0.27000.69%
Volume:93.33K
Turnover:3.64M
Market Cap:217.72M
PE:- -
High:39.43
Open:39.32
Low:38.45
Close:39.10
52wk High:42.63
52wk Low:13.60
Shares:5.53M
Float Shares:5.53M
Volume Ratio:1.54
T/O Rate:1.69%
Dividend:17.77
Dividend Rate:45.13%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

Dow Jones
·
Sep 02

ETF Daily | MRNX Soars 20%; UCO Climbs 6%; CRDU Slides 17%; Oil Spike Lifts Leveraged Crude Funds

ETF Tracker
·
Sep 02

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 02

U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions

Reuters
·
Sep 01

Moderna to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 01

Top 10 Best-Performing US Stocks in August: Moderna Surges 156%, Palantir Leads AI Software Stocks

TradingKey
·
Sep 01

Cboe data suggests bullish flow in Moderna with shares up 0.71%

TIPRANKS
·
Sep 01

Moderna Stock (MRNA) Was the Best Performer in August

TIPRANKS
·
Sep 01

New Listing Update | Betta Pharma Re-files for Hong Kong IPO, Leveraging a Quad-Driven Model to Build a Fully Integrated Biopharmaceutical Platform

Stock News
·
Aug 31

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

TIPRANKS
·
Aug 31

August Turmoil: Bessent's Intervention and the Quiet Reveal of Policy's Hidden Hand

Deep News
·
Aug 30

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

TIPRANKS
·
Aug 29

Takeda receives FDA approval of NDA for Mimrylo

TIPRANKS
·
Aug 29

US Stocks Weekly: AI Refuel

Reuters
·
Aug 29

BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna's Big Win

Dow Jones
·
Aug 29

BioNTech on Track for Worst Day Since March After Ending Colorectal Cancer Trial

Reuters
·
Aug 29

Top Calls On Wall Street: Nvidia, SpaceX, Moderna, TeraWulf , Amazon,Marvell, and More

Tiger Newspress
·
Aug 28

Moderna Stock Falls on $2B Notes Deal: Is the Cancer Rally Still Intact?

TradingKey
·
Aug 28

Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target

MT Newswires Live
·
Aug 28